DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Using Epidemiologic Methods to Advance Comparative Effectiveness Research

Session Chair(s)

Nancy A Dreyer, PHD, MPH, FISPE

Nancy A Dreyer, PHD, MPH, FISPE

Founder

Dreyer Strategies LLC, United States

The strengths and limitations of observational studies of comparative effectiveness research will be presented, along with a discussion of epidemiologic methods, resources, and a validated scale for assessing observational study quality.

Learning Objective : Describe the use of knowledge about using epidemiologic methods for comparative effectiveness research; Discuss pros and cons of using observational methods to support comparative effectiveness research; Explain resources available to assist in understanding epidemiologic methods and evaluating studies.

Speaker(s)

Kenneth J. Rothman, DrPH, FISPE

Science Beyond the Randomized Trial

Kenneth J. Rothman, DrPH, FISPE

RTI Health Solutions, United States

Distinguished Fellow

Nancy A Dreyer, PHD, MPH, FISPE

GRACE Checklist for Observational Studies of Comparative Effectiveness Research

Nancy A Dreyer, PHD, MPH, FISPE

Dreyer Strategies LLC, United States

Founder

Hans-Georg  Eichler, MD, MSC

(How) Can Regulators Support CER?

Hans-Georg Eichler, MD, MSC

Austrian Association of Social Security Bodies, Austria

Consulting Physician

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。